who should not take retatrutide 💉 is the most powerful weight loss drug ever trialled. 28.7 percent average body weight loss in 68 weeks. Some participants lost over 30 percent of their starting body weight. The This weight-loss drug hasn't been

The caveat is that you can gain the weight right back once you get off Wegovy

For context, semaglutide 2.4 mg in the STEP 1 trial produced a mean body-weight change of -14.9% at 68 weeks versus -2.4% with placebo

Because it is used up quickly during times of stress, illness, or toxin exposure, many people find that their natural production cannot keep up with the body's demands

But its notat least, not directly

Side Effects, Safety, and Long-Term Outcomes GLP-1 medications are generally well-tolerated, but nausea, vomiting, constipation, and diarrhea occur in 20-40% of patients during dose escalation

Plaintiffs in current lawsuits allege that Eli Lilly and Company failed to adequately warn patients and healthcare providers about the severity, persistence, and potential long-term consequences of these gastrointestinal risks